---
title: "Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), all indications: Clinical trials questions"
description: "Clinical trials questions on Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Interpreting study results and Study results. Questions: How is Gardasil 9 related to Gardasil? What percentage of people develop antibodies after Gardasil 9? 2 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/gardasil-9/clinical-trials"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), all indications: Clinical trials questions

Manufacturer: Merck Sharp & Dohme LLC  
Prescribing information: [Gardasil 9](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf)  
Indication pages: [Human papillomavirus vaccination](https://www.evicenter.com/medical-information/gardasil-9--human-papillomavirus-vaccination)

## Interpreting study results

<a id="gardasil9-relation-to-gardasil"></a>

### How is Gardasil 9 related to Gardasil?

> “Efficacy and effectiveness of GARDASIL are relevant to GARDASIL 9 since the vaccines are manufactured similarly and contain 4 of the same HPV L1 VLPs.”

Source: [GARDASIL 9: Efficacy of GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant), captured 2026-11-13](https://www.merckvaccines.com/gardasil9/efficacy/#:~:text=Efficacy%20and%20effectiveness%20of%20GARDASIL,the%20same%20HPV%20L1%20VLPs.)

> “The safety profile of GARDASIL 9 and GARDASIL are similar. The postmarketing safety experience
> with GARDASIL is relevant to GARDASIL 9 since the vaccines are manufactured similarly and contain the
> same L1 HPV proteins of four of the same HPV types.”

Source: [GARDASIL 9: Prescribing information, page 9, captured 2026-11-13](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf#page=9)

## Study results

<a id="gardasil9-seropositivity"></a>

### What percentage of people develop antibodies after Gardasil 9?

> “Across all clinical trials, at least 99.2% of individuals included in the analyses for each of the nine
> vaccine HPV types became seropositive by Month 7.”

Source: [GARDASIL 9: Prescribing information, page 22, captured 2026-11-13](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf#page=22)

> “The minimum anti-HPV titer that confers protective efficacy has not been determined.”

Source: [GARDASIL 9: Prescribing information, page 18, captured 2026-11-13](https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf#page=18)

## Related pages
- [Medical information: Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant): All indications](https://www.evicenter.com/medical-information/gardasil-9)
- [Indication](https://www.evicenter.com/medical-information/gardasil-9/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/gardasil-9/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/gardasil-9/safety)
- [Specific populations](https://www.evicenter.com/medical-information/gardasil-9/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/gardasil-9/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/gardasil-9/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/gardasil-9/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/gardasil-9/access-and-coverage)
